Skip to main content
. 2023 Dec 1;10(12):1386. doi: 10.3390/bioengineering10121386

Table 2.

Feature ranking for the 1-month (left sub-table) and 1-year (right sub-table) endpoints. For each ranking method (column name), the average rank across 100 iterations is shown. An additional ranking based on the average of ranks across the four methods is shown in the AVG column. Both sub-tables are sorted by the AVG column.

1-Month VT Recurrence
AVG XGB, RFE MLP, PI RF, PI XGB, PI
HD instability 1 0 0 0 6
LVEF 2 1 4 2 1
TAPSE 3 7 1 3 4
Age 4 3 13 4 0
Clinical VT eliminated 5 2 3 5 12
LVESD 6 4 12 1 5
ICD shock 7 9 2 7 9
Clinical VT cycle length 8 6 14 6 2
E wave DT 9 5 10 11 3
Electrical storm 10 8 6 9 8
MR 11 10 8 8 10
Incessant VT 12 11 5 13 11
Inducible VT morphologies 13 16 7 10 13
NYHA 14 13 15 15 7
All VTs eliminated 15 12 11 14 15
Atrial fibrillation 16 15 9 16 14
TR III-IV 17 14 16 12 16
1-year VT recurrence
AVG XGB, RFE MLP, PI RF, PI XGB, PI
LVESD 1 1 4 0 0
Inducible VT morphologies 2 0 0 1 7
MR 3 4 1 2 6
ICD shock 4 6 2 3 9
Age 5 2 13 5 1
E wave DT 6 5 6 7 3
LVEF 7 3 12 8 2
HD instability 8 8 3 4 10
TAPSE 9 7 7 9 4
Incessant VT 10 9 5 11 11
Clinical VT cycle length 11 10 16 6 5
NYHA 12 11 8 10 8
All VTs eliminated 13 13 10 12 13
TR III-IV 14 12 14 13 12
Electrical storm 15 14 9 16 14
Atrial fibrillation 16 15 11 14 15
Clinical VT eliminated 17 16 15 15 16

HD: hemodynamic; LVEF: left ventricular ejection fraction; VT: ventricular tachycardia; LVESD: left ventricular end systolic diameter; DT: deceleration time; TAPSE: tricuspid annular plane systolic excursion; ICD: implantable cardioverter defibrillator; MR: mitral regurgitation; TR: tricuspid regurgitation; XGB, RFE; Extreme gradient boosting sing recursive feature elimination; MLP, PI: Multilayer perceptron combined with permutation importances; RF, PI: random forest combined with permutation importances; XGB, PI: Extreme gradient boosting combined with permutation importances; AVG: average.